Search

Your search keyword '"Shimizu, Satoshi"' showing total 1,157 results
Start Over Author "Shimizu, Satoshi"
1,157 results on '"Shimizu, Satoshi"'

3. Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

Author

Oh, Do-Youn, He, Aiwu Ruth, Bouattour, Mohamed, Okusaka, Takuji, Qin, Shukui, Chen, Li-Tzong, Kitano, Masayuki, Lee, Choong-kun, Kim, Jin Won, Chen, Ming-Huang, Suksombooncharoen, Thatthan, Ikeda, Masafumi, Lee, Myung Ah, Chen, Jen-Shi, Potemski, Piotr, Burris, Howard A, III, Ostwal, Vikas, Tanasanvimon, Suebpong, Morizane, Chigusa, Zaucha, Renata E, McNamara, Mairéad G, Avallone, Antonio, Cundom, Juan E, Breder, Valeriy, Tan, Benjamin, Shimizu, Satoshi, Tougeron, David, Evesque, Ludovic, Petrova, Mila, Zhen, David B, Gillmore, Roopinder, Gupta, Vineet Govinda, Dayyani, Farshid, Park, Joon Oh, Buchschacher, Gary L, Jr, Rey, Felipe, Kim, Hyosung, Wang, Julie, Morgan, Claire, Rokutanda, Nana, Żotkiewicz, Magdalena, Vogel, Arndt, and Valle, Juan W

Published
2024
Full Text
View/download PDF

5. Development of a nomogram to predict survival in advanced biliary tract cancer

Author

Imaoka, Hiroshi, Ikeda, Masafumi, Nomura, Shogo, Morizane, Chigusa, Okusaka, Takuji, Ozaka, Masato, Shimizu, Satoshi, Yamazaki, Kentaro, Okano, Naohiro, Sugimori, Kazuya, Shirakawa, Hirofumi, Mizuno, Nobumasa, Satoi, Sohei, Yamaguchi, Hironori, Sugimoto, Rie, Gotoh, Kunihito, Sano, Keji, Asagi, Akinori, Nakamura, Kazuyoshi, and Ueno, Makoto

Published
2023
Full Text
View/download PDF

6. Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer

Author

Umemoto, Kumiko, Sunakawa, Yu, Ueno, Makoto, Furukawa, Masayuki, Mizuno, Nobumasa, Sudo, Kentaro, Kawamoto, Yasuyuki, Kajiwara, Takeshi, Ohtsubo, Koushiro, Okano, Naohiro, Matsuhashi, Nobuhisa, Itoh, Shinji, Matsumoto, Toshihiko, Shimizu, Satoshi, Otsuru, Toru, Hasegawa, Hiroko, Okuyama, Hiroyuki, Ohama, Hideko, Moriwaki, Toshikazu, Ohta, Takashi, Odegaard, Justin I., Nakamura, Yoshiaki, Bando, Hideaki, Yoshino, Takayuki, Ikeda, Masafumi, and Morizane, Chigusa

Published
2023
Full Text
View/download PDF

7. Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: An exploratory analysis of JCOG1407

Author

Tezuka, Shun, Ozaka, Masato, Furuse, Junji, Yokoyama, Masayuki, Uemura, Kohei, Sano, Yusuke, Nakachi, Kohei, Imaoka, Hiroshi, Unno, Michiaki, Shirakawa, Hirofumi, Shimizu, Satoshi, Kato, Naoya, Kojima, Yasushi, Sano, Keiji, Kobayashi, Satoshi, Terashima, Takeshi, Morizane, Chigusa, Ikeda, Masafumi, and Ueno, Makoto

Published
2024
Full Text
View/download PDF

8. A Maximum Edge-Weight Clique Extraction Algorithm Based on Branch-and-Bound

Author

Shimizu, Satoshi, Yamaguchi, Kazuaki, and Masuda, Sumio

Subjects
Computer Science - Data Structures and Algorithms
Abstract

The maximum edge-weight clique problem is to find a clique whose sum of edge-weight is the maximum for a given edge-weighted undirected graph. The problem is NP-hard and some branch-and-bound algorithms have been proposed. In this paper, we propose a new exact algorithm based on branch-and-bound. It assigns edge-weights to vertices and calculates upper bounds using vertex coloring. By some computational experiments, we confirmed our algorithm is faster than previous algorithms.

Published
2018

10. Long‐term effects of ipragliflozin and pioglitazone on metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow‐up of a randomized, 24 week, active‐controlled trial

Author

Ito, Daisuke, primary, Shimizu, Satoshi, additional, Haisa, Akifumi, additional, Yanagisawa, Shinnosuke, additional, Inoue, Kazuyuki, additional, Saito, Daigo, additional, Sumita, Takashi, additional, Yanagisawa, Morifumi, additional, Uchida, Yoshihito, additional, Inukai, Kouichi, additional, and Shimada, Akira, additional

Published
2024
Full Text
View/download PDF

11. Ameliorating prediabetic subject status via fermented tea supplementation: A randomized, double-blind, parallel-group comparison study

Author

Katanasaka, Yasufumi, Sunagawa, Yoichi, Miyazaki, Yusuke, Funamoto, Masafumi, Shimizu, Satoshi, Shimizu, Kana, Yamakage, Hajime, Satoh-Asahara, Noriko, Toyama, Kazushige, Sabashi, Toru, Suzuki, Mika, Hamabe-Horiike, Toshihide, Komiyama, Maki, Wada, Hiromichi, Mori, Kiyoshi, Hasegawa, Koji, and Morimoto, Tatsuya

Published
2022
Full Text
View/download PDF

13. The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113

Author

Yamada, Ikuhiro, Morizane, Chigusa, Okusaka, Takuji, Mizusawa, Junki, Kataoka, Tomoko, Ueno, Makoto, Ikeda, Masafumi, Okano, Naohiro, Todaka, Akiko, Shimizu, Satoshi, Mizuno, Nobumasa, Sekimoto, Mitsugu, Tobimatsu, Kazutoshi, Yamaguchi, Hironori, Nishina, Tomohiro, Shirakawa, Hirofumi, Kojima, Yasushi, Oono, Takamasa, Kawamoto, Yasuyuki, Furukawa, Masayuki, Iwai, Tomohisa, Sudo, Kentaro, Okamura, Keiya, Yamashita, Tatsuya, Kato, Naoya, Shioji, Kazuhiko, Shimizu, Kyouko, Nakagohri, Toshio, Kamata, Ken, Ishii, Hiroshi, and Furuse, Junji

Published
2022
Full Text
View/download PDF

18. Why do companies participate in climate change‐related initiatives? Theoretical and empirical analyses of motivations for Japanese companies.

Author

Shimizu, Satoshi and Goto, Mika

Subjects
GOVERNMENT policy on climate change, PARIS Agreement (2016), SUSTAINABLE development, TASK forces, RENEWABLE energy sources
Abstract

The 2015 Paris Agreement accelerated the trend toward international decarbonization. Climate change initiatives, such as Science Based Targets, Renewable Energy 100%, and Task Force on Climate‐related Financial Disclosure are rapidly gaining attention as mechanisms that encourage voluntary efforts by companies to limit emissions. However, participation in these initiatives creates a conflict with the pursuit of short‐term profits. Understanding the firms' motivation for initiative participation contributes to the realization of sustainable development. This study empirically examines the motivations for large‐scale Japanese firms to participate in climate change initiatives. For this purpose, first, we update the conventional model of corporate motivations for taking environmental actions to fit the contemporary context. We then quantify individual firms' motivations based on various data and conduct regression analyses to identify the factors contributing to the firms' participation in the initiatives. The results indicate that firms have competitive and legitimate motives to participate in these initiatives. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

20. Anserine, a Histidine-Containing Dipeptide, Suppresses Pressure Overload-Induced Systolic Dysfunction by Inhibiting Histone Acetyltransferase Activity of p300 in Mice

Author

Sunagawa, Yoichi, primary, Tsukabe, Ryosuke, additional, Irokawa, Yudai, additional, Funamoto, Masafumi, additional, Suzuki, Yuto, additional, Yamada, Miho, additional, Shimizu, Satoshi, additional, Katanasaka, Yasufumi, additional, Hamabe-Horiike, Toshihide, additional, Kawase, Yuto, additional, Naruta, Ryuya, additional, Shimizu, Kana, additional, Mori, Kiyoshi, additional, Hosomi, Ryota, additional, Komiyama, Maki, additional, Hasegawa, Koji, additional, and Morimoto, Tatsuya, additional

Published
2024
Full Text
View/download PDF

21. Nobiletin, a Polymethoxyflavonoid, Activates the Desuccinylase Activity of SIRT5 and Prevents the Development of Heart Failure

Author

Sunagawa, Yoichi, primary, Funamoto, Masafumi, additional, Hamabe-Horiike, Toshihide, additional, Hieda, Kehima, additional, Yabuki, Seiichiro, additional, Tomino, Midori, additional, Ikai, Yoshimi, additional, Suzuki, Anna, additional, Ogawahara, Shintaro, additional, Yabuta, Asami, additional, Sasaki, Hana, additional, Ebe, Ayaka, additional, Naito, Shiomi, additional, Takai, Hidemichi, additional, Shimizu, Kana, additional, Shimizu, Satoshi, additional, Kawase, Yuto, additional, Naruta, Ryuya, additional, Katanasaka, Yasufumi, additional, Asakawa, Tomohiro, additional, Kan, Toshiyuki, additional, Mori, Kiyoshi, additional, Murakami, Akira, additional, Ogura, Masahito, additional, Inagaki, Nobuya, additional, Hasegawa, Koji, additional, and Morimoto, Tatsuya, additional

Published
2024
Full Text
View/download PDF

23. Evaluation of Refocus Flip Angle for Three-dimensional Proton Density-weighted Turbo Spin-echo Imaging in Cerebrovascular Black Blood MRA and Comparison with Three-dimensional Time-of-flight MRA

Author

Jingu, Ryotaro, primary, Shimizu, Satoshi, additional, Nakamuta, Ryuji, additional, Izuno, Yuta, additional, Saruwatari, Yuko, additional, Koda, Eiji, additional, Uemura, Tadahisa, additional, Takano, Koichi, additional, and Yoshimitsu, Kengo, additional

Published
2024
Full Text
View/download PDF

28. Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

Author

Maruki, Yuta, Morizane, Chigusa, Arai, Yasuhito, Ikeda, Masafumi, Ueno, Makoto, Ioka, Tatsuya, Naganuma, Atsushi, Furukawa, Masayuki, Mizuno, Nobumasa, Uwagawa, Tadashi, Takahara, Naminatsu, Kanai, Masashi, Asagi, Akinori, Shimizu, Satoshi, Miyamoto, Atsushi, Yukisawa, Seigo, Kadokura, Makoto, Kojima, Yasushi, Furuse, Junji, Nakajima, Takako Eguchi, Sudo, Kentaro, Kobayashi, Noritoshi, Hama, Natsuko, Yamanaka, Takeharu, Shibata, Tatsuhiro, and Okusaka, Takuji

Published
2021
Full Text
View/download PDF

31. Japanese Graduate Students' Experiences in Online International Development and Peace Through Sport Courses Using English-Medium Instruction During the COVID-19 Pandemic.

Author

Oishi, Junko, Sato, Takahiro, Miller, Ryan T., Nagata, Shinichi, Fuchikami, Maho, Shimizu, Satoshi, Matsumoto, Tsuyoshi, Yamaguchi, Taku, and Kim, Satbyul Estella

Abstract

The purpose of this study was to investigate five Japanese graduate (master's level) students' experiences in online courses in international development and peace through sport that used English as the medium of instruction. The study was situated in the framework of andragogy theory and used a descriptive-qualitative design using an in-depth, semistructured interview approach using online oral and written interviews. Three emergent themes were established. These recurrent themes were (a) learning online specialized content using English as a second language, (b) students' struggles in group projects through online education, and (c) students' opinions about the improvement of online education. To better support Japanese graduate students' online learning, this study encourages academic departments, administrators, and faculty to better design appropriate courses and online activities. This will contribute to a greater appreciation for the richness of sports development and peace and to increasing the availability of meaningful academic and social experiences for graduate students at Japanese universities. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study)

Author

Okano, Naohiro, Morizane, Chigusa, Nomura, Shogo, Takahashi, Hideaki, Tsumura, Hidetaka, Satake, Hironaga, Mizuno, Nobumasa, Tsuji, Kunihiro, Shioji, Kazuhiko, Asagi, Akinori, Yasui, Kohichiroh, Kitagawa, Sho, Kashiwada, Tomomi, Ishiguro, Atsushi, Kanai, Masashi, Ueno, Makoto, Ogura, Takashi, Shimizu, Satoshi, Tobimatsu, Kazutoshi, Motoya, Masayo, Nakashima, Koji, Ikeda, Masafumi, Okusaka, Takuji, and Furuse, Junji

Published
2020
Full Text
View/download PDF

37. Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD.

Author

Ikeda, Masafumi, Yamashita, Tatsuya, Ogasawara, Sadahisa, Kudo, Masatoshi, Inaba, Yoshitaka, Morimoto, Manabu, Tsuchiya, Kaoru, Shimizu, Satoshi, Kojima, Yasushi, Hiraoka, Atsushi, Nouso, Kazuhiro, Aikata, Hiroshi, Numata, Kazushi, Sato, Tosiya, Okusaka, Takuji, and Furuse, Junji

Subjects
INTRA-arterial infusions, CISPLATIN, HEPATOCELLULAR carcinoma, CLINICAL trials, OVERALL survival
Abstract

Introduction: Hepatic arterial infusion chemotherapy (HAIC) with cisplatin and lenvatinib exhibits strong antitumor effects against advanced hepatocellular carcinoma (HCC). Higher antitumor activity is expected for the combination treatment. The aim of this trial was to evaluate the efficacy and safety of lenvatinib in combination with HAIC using cisplatin in patients with advanced HCC. Methods: In this multicenter, open-labeled, single-arm, phase II trial, patients with advanced HCC categorized as Child-Pugh class A with no prior history of systemic therapy were enrolled. Patients received lenvatinib plus HAIC with cisplatin (lenvatinib: 12 mg once daily for patients ≥60 kg, 8 mg once daily for patients <60 kg; HAIC with cisplatin: 65 mg/m2, day 1, every 4–6 weeks, maximum of six cycles). The primary endpoint was the objective response rate (ORR) assessed using modified RECIST by the Independent Review Committee. The secondary endpoints were the ORR assessed using RECIST v1.1, progression-free survival, overall survival, and frequency of adverse events associated with the treatment. Results: A total of 36 patients were enrolled between September 2018 and March 2020. In the 34 evaluable patients, the ORR assessed by the Independent Review Committee using modified RECIST and RECIST v1.1 were 64.7% (95% confidence interval [CI]: 46.5–80.3%) and 45.7% (95% CI: 28.8–63.4%), respectively. The median progression-free survival and overall survival were 6.3 months (95% CI: 5.1–7.9 months) and 17.2 months (95% CI: 10.9 – not available, months), respectively. The main grade 3–4 adverse events were increased aspartate aminotransferase (34%), leukopenia (22%), increased alanine aminotransferase (19%), and hypertension (11%). Conclusion: Lenvatinib plus HAIC with cisplatin yielded a favorable ORR and overall survival and was well tolerated in patients with advanced HCC. Further evaluation of this regimen in a phase III trial is warranted. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer.

Author

Shibuki, Taro, Nakamura, Yoshiaki, Ueno, Makoto, Furukawa, Masayuki, Kawamoto, Yasuyuki, Itoh, Shinji, Umemoto, Kumiko, Sudo, Kentaro, Satoh, Taroh, Mizuno, Nobumasa, Asagi, Akinori, Okano, Naohiro, Shimizu, Satoshi, Bekaii-Saab, Tanios S., Strickler, John H, Fujisawa, Takao, Bando, Hideaki, Yoshino, Takayuki, Morizane, Chigusa, and Ikeda, Masafumi

Published
2024
Full Text
View/download PDF

39. Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.

Author

Okano, Naohiro, Morizane, Chigusa, Okusaka, Takuji, Sadachi, Ryo, Kataoka, Tomoko, Kobayashi, Satoshi, Ikeda, Masafumi, Ozaka, Masato, Mizutani, Tomonori, Sugimori, Kazuya, Todaka, Akiko, Shimizu, Satoshi, Mizuno, Nobumasa, Yamamoto, Tomohisa, Sano, Keiji, Tobimatsu, Kazutoshi, Katanuma, Akio, Gotoh, Kunihito, Yamaguchi, Hironori, and Ishii, Hiroshi

Subjects
DISEASE progression, BILE duct tumors, CONFIDENCE intervals, CANCER chemotherapy, MULTIVARIATE analysis, TREATMENT effectiveness, GEMCITABINE, RESEARCH funding, CISPLATIN, PROGRESSION-free survival, TUMOR markers, PROPORTIONAL hazards models, OVERALL survival, EVALUATION
Abstract

Background Recent studies suggest that early tumor shrinkage (ETS) and depth of response (DpR) reflect outcomes of chemotherapy in various cancers. This study evaluated the association of ETS and DpR with clinical outcomes using data from JCOG1113, which demonstrated the non-inferiority of gemcitabine plus S-1 (GS) to gemcitabine plus cisplatin (GC) for chemotherapy-naïve advanced biliary tract cancer. Material and Methods In total, 354 (289 with measurable target lesions) patients enrolled in JCOG1113 were divided into ETS-unachieved and ETS-achieved groups (≥20% tumor reduction at week 6) and DpR-low and DpR-high groups (≥40% maximum shrinkage) until 12 weeks after enrollment. The impact of ETS and DpR on survival outcome was evaluated using the multivariable Cox proportional hazard model. Results The proportions of patients in the ETS-achieved and DpR-high groups were similar between the 2 treatment arms. The hazard ratios (HRs) of progression-free survival (PFS) and overall survival (OS) for the ETS-achieved group were 0.70 (95% confidence interval (CI), 0.52-0.93) and 0.60 (95%CI, 0.44-0.81), respectively. The HRs of PFS and OS for the DpR-high group were 0.67 (95%CI, 0.48-0.94) and 0.64 (95%CI, 0.46-0.90), respectively. In the subpopulation treatment effect pattern plot analysis, most patients in the ETS-achieved group in the GC arm did not experience disease progression after 12 weeks from the landmark. Conclusion As on-treatment markers, ETS and DpR were effective tools. ETS was clinically useful, because it can be used to evaluate the outcomes of treatment early at a specific time. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

40. Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD

Author

Ikeda, Masafumi, primary, Yamashita, Tatsuya, additional, Ogasawara, Sadahisa, additional, Kudo, Masatoshi, additional, Inaba, Yoshitaka, additional, Morimoto, Manabu, additional, Tsuchiya, Kaoru, additional, Shimizu, Satoshi, additional, Kojima, Yasushi, additional, Hiraoka, Atsushi, additional, Nouso, Kazuhiro, additional, Aikata, Hiroshi, additional, Numata, Kazushi, additional, Sato, Tosiya, additional, Okusaka, Takuji, additional, and Furuse, Junji, additional

Published
2023
Full Text
View/download PDF

43. Temporality and Disappearance : Tourism and History in 'Ashikari' by Tanizaki Junichiro

Author

SHIMIZU, Satoshi

Subjects
History, 「蘆刈」, Tanizaki Junichiro, 歴史, ”Ashikari”, 観光, 谷崎潤一郎, Tourism
Abstract

This paper examines “Ashikari” (1932) by Tanizaki Junichiro. Although the work has been the subject of much discussion regarding its relationship with classical works and the structure of its narrative, this paper will clarify the contemporaneous meaning of the work by clarifying the tourist-like nature of the character “I.”The “I” of Minase has the same characteristics as those of the “the tourist gaze” ( John Urry, Jonas Larsen). It is a gaze in which the tourist projects his or her image of the tourist site onto the land and sees the site in a way that conforms to that image. This gaze has been considered to be an influence from classical works or a product of the imagination of “I,” but the development of the tourism industry is also a background to the development of this gaze, and it is considered to be a gaze generated by such a system. In addition, when “I” visited Minase around 1930, tourism for the purpose of historical exploration was in vogue. In this sense, “I” can be said to have the characteristics of a tourist. “The man” also talks about Oyu in a way that matches the gaze of the “I.” “The man’s” narrative is based on the classical image of Oyu. By describing Oyu based on classical imagery, the “The man” adds to and amplifies these qualities, and while affirming Shinnosuke, he tries to confine Oyu within his own image. “I” and “The man” dye the subject with the preceding image and cast their gaze in accordance with their desire for it to be so. However, at the conclusion of the story, “The man” disappears. This disappearance reveals to “I” the delusional and romantic aspects of “The man’s” narrative. In addition, the disappearance of the landscape before “I” also relativizes “the tourist gaze” of “I”. This is not merely a relativization of “I’s “gaze, but also a critique of the tourism of the time.

Published
2023

45. Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study

Author

Ueno, Makoto, Morinaga, Soichiro, Hashimoto, Yusuke, Umemoto, Kumiko, Sasahira, Naoki, Saiura, Akio, Seyama, Yasuji, Honda, Goro, Ioka, Tatsuya, Takahashi, Hidenori, Miyamoto, Atsushi, Nakamori, Shoji, Unno, Michiaki, Takadate, Tatsuyuki, Mizuno, Nobumasa, Shimizu, Yasuhiro, Ueno, Hideki, Sugiyama, Masanori, Fukutomi, Akira, Shimizu, Satoshi, Okusaka, Takuji, and Furuse, Junji

Published
2021
Full Text
View/download PDF

48. 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure

Author

Kawase, Yuto, primary, Sunagawa, Yoichi, additional, Shimizu, Kana, additional, Funamoto, Masafumi, additional, Hamabe-Horiike, Toshihide, additional, Katanasaka, Yasufumi, additional, Shimizu, Satoshi, additional, Hawke, Philip, additional, Mori, Kiyoshi, additional, Komiyama, Maki, additional, Hasegawa, Koji, additional, and Morimoto, Tatsuya, additional

Published
2023
Full Text
View/download PDF

49. Supplementary Figure from Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis

Author

Hikita, Hayato, primary, Kodama, Takahiro, primary, Tanaka, Satoshi, primary, Saito, Yoshinobu, primary, Nozaki, Yasutoshi, primary, Nakabori, Tasuku, primary, Shimizu, Satoshi, primary, Hayashi, Yoshito, primary, Li, Wei, primary, Shigekawa, Minoru, primary, Sakamori, Ryotaro, primary, Miyagi, Takuya, primary, Hiramatsu, Naoki, primary, Tatsumi, Tomohide, primary, and Takehara, Tetsuo, primary

Published
2023
Full Text
View/download PDF

50. Data from Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis

Author

Hikita, Hayato, primary, Kodama, Takahiro, primary, Tanaka, Satoshi, primary, Saito, Yoshinobu, primary, Nozaki, Yasutoshi, primary, Nakabori, Tasuku, primary, Shimizu, Satoshi, primary, Hayashi, Yoshito, primary, Li, Wei, primary, Shigekawa, Minoru, primary, Sakamori, Ryotaro, primary, Miyagi, Takuya, primary, Hiramatsu, Naoki, primary, Tatsumi, Tomohide, primary, and Takehara, Tetsuo, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results